Effect of methylprednisolone on cell proliferation in C3H/HeJ spontaneous mammary tumors

Paul G Braunschweiger, J. J. Stragand, L. M. Schiffer

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The present studies were initiated to investigate the effects of methylprednisolone (MP) on the growth and cell kinetics of C3H/HeJ spontaneous mammary tumor. MP given every 12 hr in 9 doses at 10 or 20 mg/kg/dose resulted in temporary stasis of tumor growth with little or no volume regression. Cell kinetic parameters were determined by in vitro methods after MP every 12 hr in 3 doses. At both dose levels a similar 50% decrease in the tritiated thymidine labeling index was observed 2 hr after treatment. At this time, the primer-dependent DNA polymerase labeling index, an in vitro estimate of tumor growth fraction, was similar to untreated controls at both dose levels. The cell kinetic changes after MP (10 mg/kg every 12 hr in 3 doses) suggested a reversible G1 block with synchronous progression of tumor cells through the cell cycle after cessation of treatment. While synchrony was also suggested after MP (20 mg/kg every 12 hr in 3 doses), resumption of cell proliferation was delayed by 18 hr. Treatment with 5-fluorouracil and methotrexate 12 hr after cessation of MP (10 mg/kg every 12 hr in 3 doses), a time corresponding to maximal tritiated thymidine labeling index, resulted in greater tumor regression and greater regrowth delay than did 5-fluorouracil and methotrexate given at times corresponding to low tritiated thymidine labeling indexes. Tumor volume-doubling times during regrowth were significantly longer than either prior to treatment or after methotrexate and 5-fluorouracil alone.

Original languageEnglish
Pages (from-to)4510-4514
Number of pages5
JournalCancer Research
Volume38
Issue number12
StatePublished - Dec 1 1978
Externally publishedYes

Fingerprint

Methylprednisolone
Cell Proliferation
Breast Neoplasms
Methotrexate
Fluorouracil
Thymidine
Neoplasms
Growth
Withholding Treatment
DNA-Directed DNA Polymerase
Tumor Burden
Cell Cycle
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Braunschweiger, P. G., Stragand, J. J., & Schiffer, L. M. (1978). Effect of methylprednisolone on cell proliferation in C3H/HeJ spontaneous mammary tumors. Cancer Research, 38(12), 4510-4514.

Effect of methylprednisolone on cell proliferation in C3H/HeJ spontaneous mammary tumors. / Braunschweiger, Paul G; Stragand, J. J.; Schiffer, L. M.

In: Cancer Research, Vol. 38, No. 12, 01.12.1978, p. 4510-4514.

Research output: Contribution to journalArticle

Braunschweiger, PG, Stragand, JJ & Schiffer, LM 1978, 'Effect of methylprednisolone on cell proliferation in C3H/HeJ spontaneous mammary tumors', Cancer Research, vol. 38, no. 12, pp. 4510-4514.
Braunschweiger PG, Stragand JJ, Schiffer LM. Effect of methylprednisolone on cell proliferation in C3H/HeJ spontaneous mammary tumors. Cancer Research. 1978 Dec 1;38(12):4510-4514.
Braunschweiger, Paul G ; Stragand, J. J. ; Schiffer, L. M. / Effect of methylprednisolone on cell proliferation in C3H/HeJ spontaneous mammary tumors. In: Cancer Research. 1978 ; Vol. 38, No. 12. pp. 4510-4514.
@article{9a989ba198dc415e95bcffa9caa1c2ad,
title = "Effect of methylprednisolone on cell proliferation in C3H/HeJ spontaneous mammary tumors",
abstract = "The present studies were initiated to investigate the effects of methylprednisolone (MP) on the growth and cell kinetics of C3H/HeJ spontaneous mammary tumor. MP given every 12 hr in 9 doses at 10 or 20 mg/kg/dose resulted in temporary stasis of tumor growth with little or no volume regression. Cell kinetic parameters were determined by in vitro methods after MP every 12 hr in 3 doses. At both dose levels a similar 50{\%} decrease in the tritiated thymidine labeling index was observed 2 hr after treatment. At this time, the primer-dependent DNA polymerase labeling index, an in vitro estimate of tumor growth fraction, was similar to untreated controls at both dose levels. The cell kinetic changes after MP (10 mg/kg every 12 hr in 3 doses) suggested a reversible G1 block with synchronous progression of tumor cells through the cell cycle after cessation of treatment. While synchrony was also suggested after MP (20 mg/kg every 12 hr in 3 doses), resumption of cell proliferation was delayed by 18 hr. Treatment with 5-fluorouracil and methotrexate 12 hr after cessation of MP (10 mg/kg every 12 hr in 3 doses), a time corresponding to maximal tritiated thymidine labeling index, resulted in greater tumor regression and greater regrowth delay than did 5-fluorouracil and methotrexate given at times corresponding to low tritiated thymidine labeling indexes. Tumor volume-doubling times during regrowth were significantly longer than either prior to treatment or after methotrexate and 5-fluorouracil alone.",
author = "Braunschweiger, {Paul G} and Stragand, {J. J.} and Schiffer, {L. M.}",
year = "1978",
month = "12",
day = "1",
language = "English",
volume = "38",
pages = "4510--4514",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "12",

}

TY - JOUR

T1 - Effect of methylprednisolone on cell proliferation in C3H/HeJ spontaneous mammary tumors

AU - Braunschweiger, Paul G

AU - Stragand, J. J.

AU - Schiffer, L. M.

PY - 1978/12/1

Y1 - 1978/12/1

N2 - The present studies were initiated to investigate the effects of methylprednisolone (MP) on the growth and cell kinetics of C3H/HeJ spontaneous mammary tumor. MP given every 12 hr in 9 doses at 10 or 20 mg/kg/dose resulted in temporary stasis of tumor growth with little or no volume regression. Cell kinetic parameters were determined by in vitro methods after MP every 12 hr in 3 doses. At both dose levels a similar 50% decrease in the tritiated thymidine labeling index was observed 2 hr after treatment. At this time, the primer-dependent DNA polymerase labeling index, an in vitro estimate of tumor growth fraction, was similar to untreated controls at both dose levels. The cell kinetic changes after MP (10 mg/kg every 12 hr in 3 doses) suggested a reversible G1 block with synchronous progression of tumor cells through the cell cycle after cessation of treatment. While synchrony was also suggested after MP (20 mg/kg every 12 hr in 3 doses), resumption of cell proliferation was delayed by 18 hr. Treatment with 5-fluorouracil and methotrexate 12 hr after cessation of MP (10 mg/kg every 12 hr in 3 doses), a time corresponding to maximal tritiated thymidine labeling index, resulted in greater tumor regression and greater regrowth delay than did 5-fluorouracil and methotrexate given at times corresponding to low tritiated thymidine labeling indexes. Tumor volume-doubling times during regrowth were significantly longer than either prior to treatment or after methotrexate and 5-fluorouracil alone.

AB - The present studies were initiated to investigate the effects of methylprednisolone (MP) on the growth and cell kinetics of C3H/HeJ spontaneous mammary tumor. MP given every 12 hr in 9 doses at 10 or 20 mg/kg/dose resulted in temporary stasis of tumor growth with little or no volume regression. Cell kinetic parameters were determined by in vitro methods after MP every 12 hr in 3 doses. At both dose levels a similar 50% decrease in the tritiated thymidine labeling index was observed 2 hr after treatment. At this time, the primer-dependent DNA polymerase labeling index, an in vitro estimate of tumor growth fraction, was similar to untreated controls at both dose levels. The cell kinetic changes after MP (10 mg/kg every 12 hr in 3 doses) suggested a reversible G1 block with synchronous progression of tumor cells through the cell cycle after cessation of treatment. While synchrony was also suggested after MP (20 mg/kg every 12 hr in 3 doses), resumption of cell proliferation was delayed by 18 hr. Treatment with 5-fluorouracil and methotrexate 12 hr after cessation of MP (10 mg/kg every 12 hr in 3 doses), a time corresponding to maximal tritiated thymidine labeling index, resulted in greater tumor regression and greater regrowth delay than did 5-fluorouracil and methotrexate given at times corresponding to low tritiated thymidine labeling indexes. Tumor volume-doubling times during regrowth were significantly longer than either prior to treatment or after methotrexate and 5-fluorouracil alone.

UR - http://www.scopus.com/inward/record.url?scp=0018117702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018117702&partnerID=8YFLogxK

M3 - Article

VL - 38

SP - 4510

EP - 4514

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 12

ER -